Related Experiment Video
Updated: Jul 31, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review
Monique Ferguson1,2, Jaysonn Vel1, Vincent Phan1
1John Sealy School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
People with cardiometabolic diseases like type 2 diabetes and obesity face higher risks from COVID-19 infection, experiencing severe illness and poorer outcomes due to hyperinflammation. Managing inflammation and blood sugar is key for better clinical results.
Area of Science:
- Immunology
- Endocrinology
- Infectious Diseases
Background:
- Cardiometabolic diseases, including type 2 diabetes (T2D) and obesity, are linked to increased susceptibility and severity of coronavirus disease 2019 (COVID-19).
- Hyperinflammation is a proposed shared pathway contributing to poor outcomes in both cardiometabolic diseases and COVID-19.
Purpose of the Study:
- To investigate the role of shared inflammatory biomarkers between COVID-19 and cardiometabolic diseases.
- To evaluate the impact of cardiometabolic conditions on COVID-19 prognosis.
Main Methods:
- Systematic review and evaluation of published data from PubMed, SCOPUS, and WHO COVID-19 databases.
- Inclusion of English articles published from December 2019 to February 2022, with 50 articles selected from 248 identified.
Main Results:
- Individuals with diabetes or obesity exhibit an increased risk of COVID-19 infection, hospitalization, and mortality.
- Diabetic patients face a higher risk of intensive care unit admission.
- COVID-19 infection can increase the risk of developing T2D, particularly in patients with comorbidities, due to heightened inflammatory responses (hyperinflammation).
Conclusions:
- Hyperinflammation exacerbates COVID-19 prognosis in patients with cardiometabolic diseases.
- Controlling blood glucose and ameliorating inflammatory responses are crucial for improving clinical outcomes.
- Clinical evaluation of hyperinflammatory states is critical for managing COVID-19 patients with cardiometabolic conditions.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

